ABNORMAL INVOLUNTARY MOVEMENTS INDUCED BY ANTICHOLINERGIC THERAPY

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Acta Neurologica Scandinavica

• Publication date

  1974-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1600-0404.1974.tb02820.xPMID 4155220
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RECENT ADVANCES ON PAIN: PATHOPHYSIOLOGY AND CLINICAL ASPECTS

  1975cited by this paper
• NITROBLUE-TETRAZOLIUM TESTS

  1975cited by this paper
• Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia

  1974cited by this paper
• A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea.

  1974cited by this paper
• Physostigmine in choreiform movement disorders

  1974cited by this paper
• Deanol in the treatment of levodopa‐induced dyskinesias

  1974cited by this paper
• Treatment of side-effects of levodopa.

  1973cited by this paper
• The pharmacology of tardive dyskinesias.

  1973cited by this paper
• Spontaneous oral-facial dyskinesia.

  1972cited by this paper
• Central cholinergic‐anticholinergic antagonism in Huntington's chorea

  1972cited by this paper
• Cholinergic-adrenergic hypothesis of mania and depression.

  1972cited by this paper
• Hyperkinesia and changes in behavior produced in normal monkeys by L‐dopa

  1972cited by this paper
• Observations on the effect of levodopa on tardive lingual-facial-buccal dyskinesia.

  1971cited by this paper
• On the role of central catecholamines in motor activity

  1971cited by this paper
• Levodopa, involuntary movements and fusaric acid.

  1971cited by this paper
• The choreoathetoid movement disorder induced by levodopa

  1971cited by this paper
• Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• Adverse clinical side effects of levodopa therapy.

  1971cited by this paper
• Parkinsonism: Physiology, Pharmacology and Treatment

  1971cited by this paper
• Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor.

  1971cited by this paper
• Cholinergic and dopaminergic mechanisms in Huntington's chorea.

  1971cited by this paper
• THEORETICAL IMPLICATIONS OF THE USE OF L‐DOPA IN PARKINSONISM.

  1970cited by this paper
• Drug-Induced Extrapyramidal Syndromes

  1970cited by this paper
• Effect of some antiparkinsonian drugs on catecholamine neurons

  1970cited by this paper
• Effect of Tetrabenazine on Extrapyramidal Movement Disorders

  1969cited by this paper
• Antiparkinsonian Drugs: Inhibition of Dopamine Uptake in the Corpus Striatum as a Possible Mechanism of Action

  1969cited by this paper
• L-dopa and juvenile Huntington's disease.

  1969cited by this paper
• Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature.

  1968cited by this paper
• THE EFFECT OF TETRABENAZINE IN SOME HYPERKINETIC SYNDROMES

  1968cited by this paper
• Aromatic amino acids and modification of parkinsonism.

  1967cited by this paper
• Erfahrungen mit L-Dopa in der Therapie des Parkinsonismus

  1963cited by this paper
• Thiopropazate dihydrochloride (Dartal) in the treatment of Huntington's chorea.

  1962cited by this paper
• Thiopropazate dihydrochloride (Dartal) in the treatment of Huntington's chorea.

  1962cited by this paper
• Tetrabenacine treatment in persisting dyskinesia caused by psychopharmaca.

  1961cited by this paper
• Some observations on Huntington's chorea.

  1957cited by this paper
• Huntington's chorea: results of treatment with reserpine.

  1955cited by this paper
• Chlorpromazine in psychiatry.

  1955cited by this paper
• Chlorpromazine in psychiatry.

  1955cited by this paper

• Factors associated with anticholinergic-induced oral-buccal-lingual dyskinesia in Parkinson’s disease

  2023cites this paper
• D1/D5 Inverse Agonists Restore Striatal Cholinergic Interneuron Physiology in Dyskinetic Mice

  2022cites this paper
• Mechanisms of antiparkinsonian anticholinergic therapy revisited.

  2021cites this paper
• Targeting muscarinic receptor subtypes as a therapeutic approach in dystonia and Parkinson's disease

  2017influential citation
• Cholinergic modulation of the mesostriatal pathway

  2016cites this paper
• Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia

  2015cites this paper
• Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

  2015cites this paper
• Striatal cholinergic interneuron regulation and circuit effects

  2014cites this paper
• Levodopa and Decarboxylase Inhibitors: A Review of their Clinical Pharmacology and Use in the Treatment of Parkinsonism

  2012cites this paper
• Anticholinergic Agents Can Induce Oromandibular Dyskinesia

  2009cites this paper
• Effects of cholinergic and anticholinergic drugs on ketamine-induced linguopharyngeal motor activity

  2005cites this paper
• Chronic benztropine and haloperidol administration induce behaviorally equivalent pharmacological hypersensitivities separately but not in combination

  2004cites this paper
• Anticholinergics for symptomatic management of Parkinson's disease.

  2002cites this paper
• Management of Parkinson's disease: An evidence‐based review

  2002cites this paper
• Anticholinergic therapies in the treatment of Parkinson's disease

  2002cites this paper
• Drug-Induced Movement Disorders

  1997cites this paper
• Tricyclic antidepressant-induced extrapyramidal side effects.

  1997cites this paper
• Switching antipsychotic medications.

  1997cites this paper
• Reversible oral-facial dyskinesia in a patient receiving ciprofloxacin hydrochloride

  1996cites this paper
• [Parkinsonian syndrome and post-encephalitic stereotyped involuntary movements responsive to L-dopa].

  1996cites this paper
• SPASTICITY

  1996cites this paper
• Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease

  1993cites this paper
• Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.

  1993cites this paper
• Prophylactic Antiparkinson Drug Use: II. Withdrawal After Long‐Term Maintenance Therapy

  1991cites this paper
• Snipping the thread of life. Antimuscarinic side effects of medications in the elderly.

  1989cites this paper
• Dopaminergic Neurons: Basic Aspects

  1989cites this paper
• Anticholinergic Drugs and Amantadine in the Treatment of Parkinson’s Disease

  1989cites this paper
• Haloperidol alters rat CNS cholinergic system: enzymatic and morphological analyses.

  1988cites this paper
• Tricyclic-induced acute tardive dyskinesia. A case report.

  1987cites this paper
• Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.

  1986cites this paper
• Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.

  1986cites this paper
• Antiparkinsonian Medication Withdrawal in the Treatment of Tardive Dyskinesia: A Report of Three Cases

  1985cites this paper
• Anti-Parkinsonian Drugs Today

  1984cites this paper
• Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.

  1984cites this paper
• Tardive Dyskinesia: Management and New Treatment

  1984cites this paper
• Distinguishing Akathisia and Tardive Dyskinesia: A Review of the Literature

  1983cites this paper
• Tardive dyskinesia and anticholinergic drugs.

  1983cites this paper
• Discinesia tardía: Efecto adverso de la terapia con neurolépticos.

  1982cites this paper
• Reversible and irreversible tardive dyskinesia: a case report.

  1982cites this paper
• Colonic adenocarcinoma: a late complication of ureterosigmoidostomy.

  1982cites this paper
• Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.

  1982cites this paper
• The differential diagnosis of tardive dyskinesia

  1981influential citation
• The management of neuroleptic-induced CNS effects.

  1981cites this paper
• The diagnosis and treatment of neuroleptic-induced Parkinsonism.

  1981cites this paper
• Differential diagnosis of tardive dyskinesia: an overview.

  1981cites this paper
• Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism.

  1980cites this paper
• Tardive dyskinesia: clinical, biological, and pharmacological perspectives.

  1980cites this paper
• Neurological Clinical Pharmacology

  1980cites this paper
• Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders.

  1980cites this paper
• Interactions Between Acetylcholine and Dopamine in the Basal Ganglia

  1979cites this paper
• Tardive Dyskinesia and Problems of Assessment

  1979cites this paper
• Tardive dyskinesia.

  1979cites this paper
• Pharmacotherapeutic Trials in Tardive Dyskinesia

  1979cites this paper
• The Role of Cholinergic and Dopaminergic Interactions in Diseases of the Central Nervous System

  1979cites this paper
• Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.

  1979cites this paper
• Tardive dyskinesia--reversible and persistent.

  1979cites this paper
• Depot Injections and Tardive Dyskinesia

  1978cites this paper
• Drugs affecting autonomic functions or the extrapyramidal system

  1978cites this paper
• Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats.

  1978cites this paper
• Ventilatory disturbance in Riley-Day syndrome.

  1977cites this paper
• Drug therapy of tardive dyskinesia.

  1977cites this paper
• Antagonism by piperidine of levodopa effects in Parkinson disease

  1977cites this paper
• Relationship between tardive dyskinesia, l-Dopa-induced hyperkinesia and parkinsonism

  1977cites this paper
• Facial dyskinesia after antihistamines.

  1977cites this paper
• The pathophysiologic basis of tardive dyskinesia.

  1977cites this paper
• Dyskinesias Associated with Tricyclic Antidepressants

  1976cites this paper
• Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

  1976cites this paper
• Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (madopar®) in the treatment of Parkinson's disease

  1975cites this paper
• ABNORMAL INVOLUNTARY MOVEMENTS IN RELATION TO ANTICHOLINERGICS AND LEVODOPA THERAPY

  1975cites this paper